Long-term impact of the women's health initiative on HRT
- PMID: 17713777
- DOI: 10.1007/s00404-007-0442-1
Long-term impact of the women's health initiative on HRT
Abstract
Objective: To evaluate the long-term trends in the HRT following the results of the WHI, which were made public in July 2002.
Study design: An observational cohort study was performed from prescription data of estrogen containing products ordered from Tripler Army Medical Center between July 1999 and July 2005. We used automated pharmacy data to identify all estrogen products dispensed to active duty soldiers, dependent wives, and retirees during the study period. Differences in prescription rate were compared between groups using a Student's t-test.
Results: A total of 71,592 prescriptions were written for HRT. Prescriptions decreased from 1,272/month at the start of the study to 493/month at the conclusion of the study. Prior to July 2002 OBGYNs were the first to decrease their prescribing rate of estrogen, and this decrease was greater than other specialties analyzed. The frequency of HRT prescriptions decreased after July 2002 while the percentage of patients who filled HRT prescriptions increased from 68 to 72%.
Conclusions: We have found a significant decrease in prescriptions after release of the WHI initiative results. With this decrease in prescribing rate of HRT we found that a greater percentage of women actually filled their prescriptions perhaps indicating greater certainty in their choice.
Similar articles
-
Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.Menopause. 2006 Jan-Feb;13(1):125-9. doi: 10.1097/01.gme.0000191211.51232.9d. Menopause. 2006. PMID: 16607108
-
Hormone therapy use and prescription durations of menopausal women in Taiwan: a 5 years' National Cohort study.Maturitas. 2007 Nov 20;58(3):259-68. doi: 10.1016/j.maturitas.2007.08.013. Epub 2007 Oct 24. Maturitas. 2007. PMID: 17920215
-
Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial.Maturitas. 2005 Nov-Dec;52(3-4):277-85. doi: 10.1016/j.maturitas.2005.04.008. Epub 2005 Jun 9. Maturitas. 2005. PMID: 15950409
-
Hormone replacement therapy: a time for pause.CMAJ. 2002 Aug 20;167(4):357-9. CMAJ. 2002. PMID: 12197690 Free PMC article. Review. No abstract available.
-
Menopause and stroke and the effects of hormonal therapy.Climacteric. 2007 Oct;10 Suppl 2:27-31. doi: 10.1080/13697130701550903. Climacteric. 2007. PMID: 17882669 Review.
Cited by
-
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture.Drug Des Devel Ther. 2013 Jul 22;7:601-10. doi: 10.2147/DDDT.S47807. Print 2013. Drug Des Devel Ther. 2013. PMID: 23901263 Free PMC article.
-
Long-term effect of the Women's Health Initiative study on antiosteoporosis medication prescribing.J Womens Health (Larchmt). 2010 May;19(5):847-54. doi: 10.1089/jwh.2009.1441. J Womens Health (Larchmt). 2010. PMID: 20459329 Free PMC article.
-
Why do stress and urge incontinence co-occur much more often than expected?Int Urogynecol J Pelvic Floor Dysfunct. 2008 Oct;19(10):1429-40. doi: 10.1007/s00192-008-0647-2. Epub 2008 Jun 5. Int Urogynecol J Pelvic Floor Dysfunct. 2008. PMID: 18528608 Review.
-
The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis.Bone. 2013 Mar;53(1):42-50. doi: 10.1016/j.bone.2012.11.011. Epub 2012 Nov 17. Bone. 2013. PMID: 23168292 Free PMC article. Review.
-
Cellular senescence in bone.Bone. 2019 Apr;121:121-133. doi: 10.1016/j.bone.2019.01.015. Epub 2019 Jan 16. Bone. 2019. PMID: 30659978 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources